MAD2L1, mitotic arrest deficient 2 like 1, 4085

N. diseases: 98; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE Taken together, aberrant expression of cell cycle related genes (e.g., CDK1, CCNA2, CCNB1, BUB1, MAD2L1 and CDC20) and material metabolism related genes (e.g., CYP2B6, ACAA1, BHMT and ALDH2) may contribute to HCC occurrence. 28238542 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease CTD_human Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. 28284560 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease BEFREE Low expression of miR-200c-5p and remarkable overexpression of MAD2L1 was uncovered in HCC tissues and cells compared with the normal. 28609841 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE Besides, genes BIRC5, CDC20, CCNB1, BUB1B, MAD2L1 and CDK1 as the hub genes might play important roles for diagnosing and therapy of HCC. 25753876 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease BEFREE In conclusion, MAD2 is overexpressed frequently in hepatocellular carcinoma, including high-grade dysplastic nodules and early-stage small hepatocellular carcinoma, indicating that overexpression of MAD2 plays a role in the development and progression of hepatocellular carcinoma. 18715617 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease LHGDN In conclusion, MAD2 is overexpressed frequently in hepatocellular carcinoma, including high-grade dysplastic nodules and early-stage small hepatocellular carcinoma, indicating that overexpression of MAD2 plays a role in the development and progression of hepatocellular carcinoma. 18715617 2008
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE Mutation analysis of p31comet gene, a negative regulator of Mad2, in human hepatocellular carcinoma. 17934339 2007
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease LHGDN Our findings suggest that MAD2 deficiency may cause a mitotic checkpoint defect in hepatoma cells. 15591789 2005
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 GeneticVariation disease BEFREE These results suggest that mutations of the hsMAD2, hBUB1 and hBUB3 genes are very rare in bladder tumors and that hsMAD2 alterations are also infrequent in soft-tissue sarcomas and hepatocellular carcinomas. 11400114 2001